Uveal metastasis of thyroid carcinomas. About 3 cases

被引:3
|
作者
Hamza, Fatma [1 ]
Amouri, Wissem [1 ]
Jardak, Issam [1 ]
Kallel, Faouzi [1 ]
Charfeddine, Salma [1 ]
Guermazi, Fadhel [1 ]
机构
[1] Hop Habib Bourguiba, Serv Med Nucl, Sfax 3062, Tunisia
来源
PRESSE MEDICALE | 2015年 / 44卷 / 03期
关键词
CHOROIDAL METASTASIS; ORBITAL METASTASES; PAPILLARY; SECONDARY; CANCER; GLAND; EYE;
D O I
10.1016/j.lpm.2014.06.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective > To study the characteristics of ocular metastases of thyroid carcinomas through three observations of patients. Results > Three patients aged respectively 41, 55 and 66 years were followed for thyroid carcinoma. All patients were treated by surgery followed by IRA therapy. They developed ocular metastases after a mean period of 10 years after thyroidectomy. They presented in addition multiple secondary sites such as bone, lungs and cerebrum. The uveal lesion was unilateral and localized at the choroid or iris. The predominant symptomatology was decreased visual acuity. The diagnosis was based on ophthalmoscopic examination and post-IRA therapy scan and was confirmed by anatomopathological study. Treatment options were respectively IRA therapy, sectoral iridectomy and enucleation. Evolution was fatal in 2 cases and towards aggravation for one case. Conclusion > Uveal metastases of thyroid cancer are associated with a pejorative prognosis. Ophthalmologic follow-up is necessary when patient presents warning sign mainly with metastatic follicular carcinoma. Conversely, thyroid carcinoma should be considered in the differential diagnosis of a uveal mass of unknown origin.
引用
收藏
页码:E67 / E74
页数:8
相关论文
共 50 条
  • [21] Sequential TKI treatments for iodine-refractory differentiated thyroid carcinomas.
    de la Fouchardiere, Christelle
    Massicotte, Marie-Helene
    Borget, Isabelle
    Brassard, Maryse
    Claude-Desroches, Mederic
    Giraudet, Anne Laure
    Docao, Christine
    Bonichon, Francoise
    Chougnet, Cecile
    Leboulleux, Sophie
    Baudin, Eric
    Schlumberger, Martin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] IODINE-CONCENTRATING THYROID CARCINOMAS - A REPORT OF 3 CASES
    EGMARK, A
    LARSSON, LG
    LILJESTRAND, A
    RAGNHULT, I
    [J]. ACTA RADIOLOGICA, 1953, 39 (05) : 423 - 433
  • [23] OCCULT THYROID METASTASIS FROM UNTREATED UVEAL MELANOMA
    GHERARDI, G
    SCHERINI, P
    AMBROSI, S
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1985, 103 (05) : 689 - 691
  • [24] ABOUT OVARIAN METASTASIS OF GASTROINTESTINAL CARCINOMAS
    LUCAS, M
    [J]. JOURNAL DE CHIRURGIE, 1988, 125 (03): : 223 - 223
  • [25] UVEAL METASTASIS - STATISTICAL STUDY FROM 133 CASES
    BEATI, D
    ZOGRAFOS, L
    EGGER, E
    CHAMOT, L
    BERCHER, L
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1994, 204 (05) : 344 - 347
  • [26] Nomogram To Predict Subsequent Bone Metastasis in Patients with Non Metastatic Breast Carcinomas.
    Lousquy, R.
    Delpech, Y.
    Rouzier, R.
    Gligorov, J.
    Hsu, L.
    Barranger, E.
    Pusztai, L.
    Uzan, S.
    Hortobagyi, G. N.
    Coutant, C.
    Ibrahim, N. K.
    [J]. CANCER RESEARCH, 2011, 71
  • [27] Brain metastasis from papillary thyroid carcinomas
    Tsuda, Kyoji
    Tsurushima, Hideo
    Takano, Shingo
    Tsuboi, Koji
    Matsumura, Akira
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (05) : 817 - 819
  • [28] Post operative loco-regional persistance and recurrences of differentiated thyroid carcinomas.
    Proye, C
    Gontier, A
    Capuano, G
    Combemale, F
    Carnaille, B
    Decoulx, M
    Wemeau, JL
    LecomteHoucke, M
    [J]. ANNALES D ENDOCRINOLOGIE, 1997, 58 (03) : 233 - 239
  • [29] Cholecystokinin/B-gastrin receptor expression in human medullary thyroid carcinomas.
    Blaeker, M
    Tometten, M
    Schulz, M
    Arlt, D
    Hoeppner, W
    Hoang-Vu, C
    de Weerth, A
    von Schrenck, T
    Greten, H
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A297 - A297
  • [30] Phase I/II trial of gemcitabine plus treasulfan (GeT) in stage IV uveal melanoma and carcinomas.
    Schmittel, AH
    Schuster, R
    Bechrakis, N
    Siehl, J
    Foerster, MH
    Thiel, E
    Keilholz, U
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 716S - 716S